We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient.
- Authors
Shimizu, Kazuhiro; Tabata, Tsuyoshi; Iwakawa, Masahiro; Sato, Shuji; Kinoshita, Toshio
- Abstract
A 72-year-old man presented to our clinic with hypertension. Arterial stiffness evaluated by cardio ankle vascular index (CAVI) was markedly increased at 13.5. We treated him using 80 mg/day of valsartan for three months. CAVI was decreased from 13.5 to 13.0. However, his BP fluctuations were still high. We changed the treatment to angiotensin receptor-neprilysin inhibitor (ARNI) with increasing doses up to 400 mg. Independent of the change in blood pressure at the time of measurement, CAVI improved with ARNI dose. Hypertension treatment with an awareness of the cardio-vascular interaction might be a possibility prevents future heart failure development effectively.
- Subjects
HYPERTENSION; ENTRESTO; VALSARTAN; BLOOD pressure measurement; ARTERIAL diseases
- Publication
International Medical Case Reports Journal, 2023, Vol 16, p461
- ISSN
1179-142X
- Publication type
Case Study
- DOI
10.2147/IMCRJ.S422196